Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hepatitis B Vaccine (Jiangsu Province Centers for Disease Control and Prevention)
- Development stage
- Unknown
- Lead developer
- Jiangsu Provincial Center for Disease Control and Prevention
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
A recombinant protein subunit vaccine produced in *Saccharomyces cerevisiae* yeast, containing the hepatitis B surface antigen (HBsAg). This vaccine is designed to provide active immunization against hepatitis B virus (HBV) infection. It was evaluated in a Phase 3 clinical trial (NCT01415024) conducted by the Jiangsu Province Centers for Disease Control and Prevention, which compared the safety and immunogenicity of 10µg/0.5ml and 5µg/0.5ml doses in infants and other age groups. The vaccine is typically administered via a three-dose intramuscular injection schedule at 0, 1, and 6 months to induce protective levels of anti-HBs antibodies.
- Other names
- hepatitis B vaccine-Jiangsu Province Centers for Disease Control and Prevention-hepatitis BHepatitis B Vaccine (Recombinant, Saccharomyces cerevisiae)10µg Hepatitis B Vaccine5µg Hepatitis B Vaccine
02
Targets
HBsAg (Hepatitis B surface antigen)
Beyond the preview
Go deeper on Hepatitis B Vaccine (Jiangsu Province Centers for Disease Control and Prevention).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hepatitis B Vaccine (Jiangsu Province Centers for Disease Control and Prevention).